Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-06-28Clinical Trial Update: Stanford Accelerated Recovery Trial (START) [Phase 3]
Phase 3 clinical trial START for pain and breast cancer has been terminated; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-06-28Clinical Trial Update: MINT I Multi- Institutional Neo-adjuvant Therapy MammaPrint Project I [Phase 4]
The MINT I trial, a multi-institutional Phase 4 study evaluating neo-adjuvant therapy guided by the MammaPrint assay in breast cancer, has b…
-
CLINICAL_TRIALS research · 2018-06-28Clinical Trial Update: BRCA Main Home Nutritional Intervention-random Study [NA]
Clinical trial update for a BRCA mutation-related nutritional intervention; no status or results provided.
-
CLINICAL_TRIALS research · 2018-06-27Clinical Trial Update: Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry
This completed prospective registry study evaluates how the MammaPrint genomic test influences adjuvant and neoadjuvant treatment decisions …
-
CLINICAL_TRIALS trial_result · 2018-06-27Clinical Trial Update: Intravenous Ascorbic Acid Supplementation in Neoadjuvant Chemotherapy for Breast Cancer [Phase 1, Phase 2]
An update on a Phase 1/Phase 2 trial evaluating intravenous ascorbic acid supplementation in neoadjuvant chemotherapy for breast cancer; the…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-06-26Clinical Trial Update: Trial of Pregabalin for Granulocyte Colony-stimulating Factor (GCSF)-Induced Bone Pain [Phase 2]
Phase 2 trial of pregabalin for G-CSF-induced bone pain in patients with breast cancer or lymphoma was terminated, with results posted in 20…
-
CLINICAL_TRIALS research · 2018-06-26Clinical Trial Update: Impact of 5-fraction Stereotactic Partial Breast Irradiation and Whole Breast Irradiation on Cosmetic Outcome and Patient-reported Outcomes in Early-stage Breast Cancer
A clinical trial update examining how 5-fraction stereotactic partial breast irradiation compares with whole breast irradiation in terms of …
-
CLINICAL_TRIALS trial_result · 2018-06-25Clinical Trial Update: Vitamin D and Breast Cancer Biomarkers in Female Patients [Phase 3]
Phase 3 trial investigating the effect of vitamin D on biomarkers in female breast cancer patients. The study is completed with results post…
-
CLINICAL_TRIALS trial_result · 2018-06-25Clinical Trial Update: Effects of Herbal Products on Reduction of Radiation-induced Dermatitis in Breast Cancer Patients [NA]
This completed clinical trial evaluated whether herbal products can reduce radiation-induced dermatitis in breast cancer patients.
-
CLINICAL_TRIALS research · 2018-06-25Clinical Trial Update: Immune Effects in Patients Treated With Whole Breast Irradiation [NA]
This document reports a clinical trial update on immune effects in patients treated with whole breast irradiation for breast cancer; the tri…
-
CLINICAL_TRIALS research · 2018-06-20Clinical Trial Update: The LightPath® Breast Cancer Study [NA]
This is a clinical trial update for the LightPath Breast Cancer Study sponsored by Lightpoint Medical Limited. The entry notes breast cancer…
-
CLINICAL_TRIALS research · 2018-06-20Clinical Trial Update: A Prospective Observational Study About Adjuvant or Neoadjuvant Chemotherapy Related Adverse Effects in Postmenopausal Breast Cancer Patients
This document describes a prospective observational study evaluating adverse effects associated with adjuvant or neoadjuvant chemotherapy in…
-
CLINICAL_TRIALS trial_result · 2018-06-20Clinical Trial Update: Non-interventional Study With Nab-Paclitaxel (Abraxane®)
This is a completed non-interventional study evaluating nab-paclitaxel (Abraxane) in patients with metastatic breast cancer. The update indi…
-
CLINICAL_TRIALS research · 2018-06-19Clinical Trial Update: Evaluation of a Three Dimensional Functional Metabolic Imaging and Risk Assessment System in Classifying Women for Likelihood of Breast Cancer [NA]
This clinical trial update reports on evaluating a three-dimensional functional metabolic imaging and risk assessment system intended to cla…
-
CLINICAL_TRIALS research · 2018-06-19Clinical Trial Update: Irinotecan for Advanced and Metastatic Breast Cancer [Phase 2]
A Phase 2 clinical trial update evaluating irinotecan for advanced and metastatic breast cancer; the current trial status is listed as UNKNO…
-
CLINICAL_TRIALS trial_result · 2018-06-19Clinical Trial Update: Pilot Study of Patient's Adherence to TYKERB™/TYVERB™ + Capecitabine in Metastatic Breast Cancer
Pilot study update evaluating patient adherence to lapatinib (TYKERB/TYVERB) plus capecitabine in metastatic breast cancer; the trial sponso…
-
CLINICAL_TRIALS trial_result · 2018-06-19Clinical Trial Update: Study of Biomarker Profiles in Asia Pacific erb2+/HER2 Breast Cancer Patients Treated With Lapatinib
A completed clinical trial evaluating biomarker profiles in Asia Pacific HER2-positive breast cancer patients treated with lapatinib.
-
CLINICAL_TRIALS trial_result · 2018-06-19Clinical Trial Update: Comparison of Contrast Enhanced Mammography to Breast MRI in Screening Patients at Increased Risk for Breast Cancer [NA]
A completed trial comparing contrast-enhanced mammography to breast MRI for screening women at increased risk of breast cancer. The study ev…
-
CLINICAL_TRIALS research · 2018-06-19Clinical Trial Update: Evaluation of a 3D Functional Metabolic Imaging and Risk Assessment System in Classifying Women for Likelihood of Breast Cancer [NA]
An evaluation of a 3D functional metabolic imaging and risk assessment system intended to classify women by their likelihood of breast cance…
-
CLINICAL_TRIALS trial_result · 2018-06-19Clinical Trial Update: Evaluation of Real Imaging's 3D Functional Metabolic Imaging and Risk Assessment (MIRA) System [NA]
A clinical trial update for Real Imaging's 3D Functional Metabolic Imaging and Risk Assessment (MIRA) System evaluating breast cancer; the s…
-
CLINICAL_TRIALS research · 2018-06-18Clinical Trial Update: A Biomarker Study of Palbociclib + Fulvestrant for Second, and Third Line of Postmenopausal Women With hr+/her2- Advanced Breast Cancer [Phase 2]
Phase 2 biomarker study evaluating the combination of palbociclib and fulvestrant in second- or third-line HR+/HER2-negative advanced breast…
-
CLINICAL_TRIALS trial_result · 2018-06-15Clinical Trial Update: Breast Cancer Long-term Outcome of Cardiac Dysfunction
An update detailing the long-term cardiac outcomes observed in breast cancer patients enrolled in the NCT01904331 trial.
-
CLINICAL_TRIALS trial_result · 2018-06-14Clinical Trial Update: Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer [Phase 1]
Phase 1 study evaluating ganetespib with paclitaxel, trastuzumab, and pertuzumab in metastatic HER2-positive breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-06-12Clinical Trial Update: Tracking Physical Activity Throughout Chemotherapy for Breast Cancer
A completed clinical trial tracking physical activity levels in patients undergoing chemotherapy for breast cancer, focusing on activity mon…
-
CLINICAL_TRIALS trial_result · 2018-06-12Clinical Trial Update: A Dose-Finding Study of Pertuzumab (Perjeta) in Combination With Trastuzumab (Herceptin) in Healthy Male Participants and Women With Early Breast Cancer (EBC) [Phase 1]
This document reports the completion of a Phase 1 dose-finding study evaluating pertuzumab in combination with trastuzumab in healthy male p…